CARCINOEMBRYONIC ANTIGEN - ANVISA Registration 80048490013

Access comprehensive regulatory information for CARCINOEMBRYONIC ANTIGEN in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80048490013 and manufactured by manufacturer not specified. The registration is held by USA DIAGNOSTICA LTDA with validity until Oct 16, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTIC DIVISION, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80048490013
2 Related Devices
Registration Details
ANVISA Registration Number: 80048490013
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

CARCINOEMBRYONIC (CEA)
Risk Class III

Registration Details

80048490013

25351263877200654

02330159000108

Company Information

Dates and Status

Oct 16, 2006

16/10/2026

09/18/2025 19:00:01

CARCINOEMBRYONIC (CEA)
Risk Class III

Registration Details

80048490013

25351263877200654

02330159000108

Company Information

MONOBIND INC.
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Oct 16, 2006

16/10/2026

09/18/2025 19:00:01